ROCK1 and prostate carcinoma: To sum up, to our knowledge, the current study firstly provided evidences to certify genetic variants in the RhoA/ROCK1 pathway, especially rs2269736 and combined risk alleles may be promising novel predictors to forecast development, progression and prognosis of prostate cancer.